Takeda Pharmaceuticals International GmbH has expanded its presence in Latin America with the addition of a wholly-owned subsidiary in Peru. Takeda Peru will be headquartered in Lima and will be responsible for the sales and marketing of Takeda's products in Peru.
Takeda has a direct presence in Brazil, Mexico, Argentina, Venezuela, Colombia, Ecuador and now Peru. According to IMS Market Prognosis, pharmaceutical sales in those countries totaled $60 billion in 2012 and are expected to grow at a compound annual rate of 12.5% between 2013 and 2017.
It is estimated that Peru’s GDP totaled $200 billion in 2012 while pharmaceutical sales amounted to $1.5 billion and are expected to continue to grow by 8% during 2013*.
Julio Cesar Acevedo Orrego has been appointed country manager for Peru. He joins the organization from Takeda Colombia, where he headed the Takeda Sales and Marketing organization following the acquisition of Farmacol Laboratories.
Source: Takeda Pharmaceuticals
